Applied Biosystems™ Clariom™ D Pico Assay, human, 12 Reactions

Applied Biosystems™ Clariom™ D Pico Assay, human, 12 Reactions

Accelerate your biomarker discovery from deep within the transcriptome with Clariom D Pico Assays for human samples, the next generation of transcriptome-level expression profiling tools. Human Clariom D Pico Assays provide a highly detailed view of the transcriptome and offer the fastest path to the results you need for your research. Clariom D Pico Assays allow translational research scientists to generate high-fidelity biomarker signatures quickly and easily. Based on industry-leading microarray technology, the novel Clariom D Pico Assay design provides the most intricate transcriptome-wide gene- and exon-level expression profiles, including the ability to detect alternative splicing events of coding and long non-coding (lnc)RNA, in a single three-day experiment.

The number of known transcribed genes has expanded rapidly in recent years, providing more sources for actionable biomarkers, such as transcript variants and lncRNA, that can be used for clinical utility and advancing our understanding of disease mechanisms. Such biomarkers can be missed by lengthy, complex, and costly sequencing and targeted expression approaches, leading to irreproducible signatures and wasted time and money.

Features

• Rapidly identify complex disease signatures from >540,000 transcripts sourced from the largest number of public databases, the most comprehensive coverage of the human transcriptome available, to ensure biomarkers are not missed.
• Confidently detect genes, exons, and alternative splicing events that give rise to coding RNA and lncRNA isoforms.
• Detect rare and low-expressing transcripts otherwise not detected by common sequencing approaches.
• Go from data to insight in minutes with intuitive, highly visual, free analysis software.
• Generate robust expression profiles from as little as 100 pg of total RNA—as few as 10 cells.
• Utilize RNA from various sample types including blood, cells, and fresh/fresh-frozen or FFPE tissues.
• Preserve sample integrity and reduce data variability with an assay that does not require a globin or rRNA removal step.

Contents

• Control HeLA RNA
• Hybridization Control Kit
• WT Pico Amplification Kit, Module 1
• WT Pico Amplification Kit, Module 2
• WT Pico Amplification Kit, Module 3
• Clariom D 10 Arrays, human
• Clariom D 2 Arrays, human